
Sally Beauty rose 33.2% from $14.23 to $18.96, ahead of the S&P 500's +13.3%. Its worst day was Feb 10 (−8.2%), and its low came May 18 at $11.82.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.48 beat the $0.47 estimate on $943.2M revenue (est. $941.6M); FY revenue guidance of $3.7B–$3.8B against the $3.7B consensus.
+5.2% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $0.44 beat the $0.41 estimate on $903.4M revenue (est. $901.7M); FY revenue guidance of $3.7B–$3.8B against the $3.7B consensus.
−7.5% · S&P 500 +0.2%
Sally Beauty shares rose 7.5%, while the S&P 500 fell 0.0%.
+7.5% · S&P 500 0.0%
EPS of $0.55 beat the $0.53 estimate on $935.5M revenue (est. $938.7M); FY revenue guidance of $3.7B–$3.7B against the $3.7B consensus.
+7.7%, the year's best day · S&P 500 +1.4%
EPS of $0.62 beat the $0.60 estimate on $952.5M revenue (est. $949.7M); Q1 revenue guidance of $945.0M–$955.0M against the $948.3M consensus.
+5.4% · S&P 500 −0.4%
Where it ended: a close of $18.96 on Nov 13, 2026. Up next: Q1 2027 earnings on Feb 8, 2027 (EPS est. $0.51, revenue est. $919.0M).
Nothing in the past 12 months.
All SBH dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SBH and SPY from Benzinga historical bars. Not investment advice.